Dr Brent Doolan
Dr Brent Doolan is a senior dermatology registrar at St John’s Institute of Dermatology in London, with a specialist interest in paediatric dermatology and genetic skin disorders. He holds a joint academic appointment with the Genetic Skin Disease Group at King’s College London, where his research focuses on genodermatoses including epidermolysis bullosa, cutaneous mastocytosis, and Ehlers-Danlos syndrome. Brent has co-authored multiple peer-reviewed publications and contributed to national and international clinical trials. He is actively involved in the British Society for Skin Care in Immunocompromised Individuals (BSSCII) and the International Skin Working Group for Ehlers-Danlos syndrome.
Dr Brent Doolan
He will use the Ellison-Cliffe Travelling Fellowship to undertake a one-year clinical and research fellowship at the Hospital for Sick Children (SickKids) in Toronto, Canada. During this time, he will gain hands-on experience in complex paediatric dermatology, including vascular anomalies, localised morphea, epidermolysis bullosa, Ehlers-Danlos syndrome, and other rare genodermatoses. Brent will also collaborate with international colleagues on genetic skin disease research and contribute to the hospital’s Precision Child Health initiative.
“Receiving the Ellison-Cliffe Travelling Fellowship is an incredible privilege that marks a pivotal moment in my career. It provides not only vital financial support but also a strong endorsement of my commitment to advancing paediatric dermatology, particularly in the care of children with rare and genetic skin conditions. The opportunity to train at a world-renowned centre like SickKids will allow me to gain specialised expertise and bring back valuable clinical, research, and educational skills to the NHS — helping to address a recognised shortage of paediatric dermatology specialists and ultimately improve outcomes for patients and families.
“I’m incredibly grateful to the Royal Society of Medicine for supporting this pivotal step in my career. The Fellowship not only enables an international collaboration that will advance care for children with rare skin diseases, but also reflects the RSM’s commitment to fostering future leaders in academic medicine and global healthcare innovation.”